| Literature DB >> 19748858 |
Michael Brehm1, F Picard, P Ebner, G Turan, E Bölke, M Köstering, P Schüller, T Fleissner, D Ilousis, K Augusta, M Peiper, Ch Schannwell, B E Strauer.
Abstract
BACKGROUND: The aim of the present study was to determine whether regular exercise training (ET) is effective at promoting the mobilization of CPCs and improving their functional activity in patients with recently acquired myocardial infarction (STEMI). Regular physical training has been shown to improve myocardial perfusion and cardiovascular function. This may be related in part to a mobilization of bone marrow-derived circulating progenitor cells (CPCs) as well as an enhanced vascularisation.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19748858 PMCID: PMC3351971 DOI: 10.1186/2047-783x-14-9-393
Source DB: PubMed Journal: Eur J Med Res ISSN: 0949-2321 Impact factor: 2.175
Figure 1Enrollment and outcomes.
Figure 2Flow chart of the prospective controlled clinical study. AMI, acute myocardial infarction.
Figure 3Representative flow cytometry gating strategy for CD45.
Figure 4Representative photos of a migration assay from an AMI patient with exercise training; before exercise training (t. Cells were evaluated 24 h after seeding 3 × 106 MNCs per ml in the upper compartiment of a boyden chamber. The assay showed a significant increase of migrated cells after the exercise training.
Characteristics of patients
| Exercise Training after AMI | Control- Patients with AMI | p | |
|---|---|---|---|
| No. of patients | 25 | 12 | n.s. |
| Gender m/w | 21/4 | 7/5 | n.s. |
| Age (yrs) | 60 ± 9 | 63 ± 10 | n.s. |
| Body-Mass Index (kg/m2) | 27.30 ± 2.4 3 | 27.4 ± 3.94 | n.s. |
| NYHA-classification | 2.64 ± 0.57 | 2.75 ± 0.62 | n.s. |
| I/II/III/IV | 0/10/14/1 | 0/4/7/1 | |
| BNP level, pg/ml | 121 ± 94 | 127 ± 78 | n.s. |
| 2.16 ± 0.83 | 2.5 ± 0.7 1 | n.s. | |
| 1/2/3 - coronary vessel disease | 7/8/10 | 2/3/7 | |
| LAD/LCX/RCA | 10/7/8 | 5/3/4 | |
| 24 (96) | 12 (100) | ||
| Smoking | 10 (40) | 5 (42) | n.s. |
| Hypercholesterolemia | 25 (100) | 12 (100) | n.s. |
| Diabetes mellitus | 4 (16) | 2 (17) | n.s. |
| Hypertension | 18 (72) | 9 (75) | n.s. |
| Positive family History | 8 (32) | 4 (33) | n.s. |
| Acetylsalicylacid | 25 (100) | 12 (100) | n.s. |
| Clopidogrel | 24 (96) | 12 (100) | n.s. |
| Beta-blocker | 25 (100) | 12 (100) | n.s. |
| ACE-inhibitor or AT-1 antagonist | 25 (100) | 11 (90) | n.s. |
| Statin | 25 (100) | 12 (100) | n.s. |
| CPK [U/L] | 1196 ± 1463 | 1002 ± 1099 | n.s. |
| CPK-MB (U/L) | 189 ± 259 | 136 ± 219 | n.s. |
| Troponin I (ng/ml) | 21.5 ± 15.3 | 12.4 ± 9.5 | n.s. |
| LDH (U/L) | 545 ± 551 | 319 ± 164 | n.s. |
| CRP (mg/dl) | 5.28 ± 7.53 | 3.98 ± 5.41 | n.s. |
Response to exercise training and traditionaly rehabilitation in patients with STEMI evaluated by ergometry, exercise echogardiography, exercise spiroergometry and BNP (brain natriuretic peptide)
| Clinical status | t0 | t1 | p+ | t2 | p# | p§ |
|---|---|---|---|---|---|---|
| exercise training | 2.64 ± 0.57 | 1.32 ± 0.4 8 | < 0.001 | 1.52 ± 0.51 | 0.096 | < 0.001 |
| Controls | 2.75 ± 0.62 | 2.25 ± 0.6 2 | 0.083 | 2.42 ± 0.52 | n.s. | n.s. |
| p | n.s. | < 0.001 | < 0.001 | |||
| exercise train ing | 121 ± 94 | 75 ± 47 | < 0.001 | 54 ± 42 | < 0.0 01 | < 0.001 |
| controls | 127 ± 78 | 111 ± 80 | n.s. | 92 ± 63 | n.s. | n.s. |
| p | n.s. | n.s. | 0.080 | |||
| exercise train ing | 101 ± 33 | 137 ± 53 | < 0.001 | |||
| controls | - | - | ||||
| p | - | - | ||||
| exercise train ing | 5.68 ± 2.03 | 7.18 | 0.007 | |||
| controls | - | - | ||||
| p | - | - | ||||
| exercise train ing | 46 ± 12 | 49 ± 12 | 0.028 | 49 ± 11 | n.s. | 0.0 09 |
| controls | 48 ± 13 | 49 ± 16 | n.s. | 49 ± 12 | n.s. | n.s. |
| p | n.s. | n.s. | n.s. | |||
| exercise train ing | 57 ± 14 | 60 ± 14 | 0.031 | 60 ± 15 | n.s. | 0.0 20 |
| controls | 57 ± 6 | 58 ± 7 | n.s. | 59 ± 8 | n.s. | n.s. |
| p | n.s. | n.s. | n.s. | |||
| exercise train ing | 123 ± 47 | 140 ± 53 | 0.004 | 137 ± 52 | n.s. | 0.0 11 |
| controls | 125 ± 33 | 122 ± 41 | n.s. | 131 ± 44 | n.s. | n.s. |
| p | n.s. | n.s. | n.s. | |||
| exercise train ing | 1641 ± 522 | 1842 ± 724 | 0.017 | 1855 ± 695 | n.s. | 0.0 12 |
| controls | 1389 ± 547 | 1439 ± 465 | n.s. | 1851 ± 429 | 0.050 | n.s. |
| p | n.s. | n.s. | n.s. | |||
| exercise train ing | 20.0 ± 4.3 | 22.5 ± 6.5 | 0.015 | 22.9 ± 6.6 | n.s. | 0.0 12 |
| controls | 17.6 ± 5.6 | 17.3 ± 4.5 | n.s. | 21.7 ± 5.0 | 0.093 | n.s. |
| p | n.s. | 0.096 | n.s. |
EF = left ventriculare ejection fraction; VO2max = maximum oxygen consumption; BNP = brain natriuretic peptide; Values are mean ± SD. p+ = t0 vs. t1 ; p# = t1 vs. t2; p§ = t0 vs. t2
Figure 5Quantitative evaluation of CD45. Patients with exercise training shows a temporarily increase of the CPCs between t0 and t1. In the control group (patients with traditional rehabilitation) were no differences observed. Values are expressed as total numbers of CD45+/CD34+ cells, respectively CD45+/CD133+ cells, related to 1 × 106 MNCs. Values are mean ± SD. t0, before exercise training; t1, after exercise training; t2, 3 months after exercise training.
Response to exercise training and traditionaly rehabilitation in patients with STEMI evaluated by ergometry, exercise echogardiography, exercise spiroergometry and BNP (brain natriuretic peptide)
| t0 | t1 | p+ | t2 | p# | p§ | |
|---|---|---|---|---|---|---|
| exercise training | 257 ± 102 | 302 ± 128 | 0.022 | 269 ± 117 | n.s. | n.s. |
| controls | 275 ± 68 | 254 ± 66 | n.s. | 268 ± 69 | n.s. | n.s. |
| p | n.s. | n.s. | n.s. | |||
| exercise training | 64 ± 26 | 88 ± 46 | 0.023 | 68 ± 32 | 0.0 18 | n.s. |
| controls | 73 ± 22 | 58 ± 19 | 0.075 | 72 ± 23 | n.s. | n.s. |
| p | n.s. | 0.0 60 | n.s. | |||
| exercise training | 113 ± 12 | 199 ± 57 | < 0.001 | 130 ± 37 | < 0.001 | 0.055 |
| controls | 127 ± 30 | 128 ± 41 | n.s. | 112 ± 10 | n.s. | n.s. |
| p | n.s. | < 0.001 | n.s. | |||
| exercise training | 121 ± 19 | 242 ± 95 | < 0.001 | 134 ± 44 | < 0.001 | n.s. |
| controls | 142 ± 45 | 134 ± 44 | n.s. | 110 ± 12 | 0.0 60 | n.s. |
| p | n.s. | < 0.001 | n.s. | |||
| exercise training | 50 ± 33 | 46 ± 33 | n.s. | 39 ± 28 | n.s. | n.s. |
| controls | 84 ± 51 | 52 ± 53 | 0.058 | 26 ± 29 | n.s. | 0.009 |
| p | 0.065 | n.s. | n.s. | |||
| exercise training | 13 ± 9 | 12 ± 7 | n.s. | 18 ± 15 | n.s. | n.s. |
| controls | 23 ± 16 | 14 ± 12 | n.s. | 7 ± 7 | n.s. | 0.092 |
| p | 0.095 | n.s. | 0.0 27 |
Data are shown as mean ± SD. Amount of CD45+/CD34+cells and CD45+/CD133+cells are expressed as cells per 1 × 106 MNCs. Migration capacity is expressed in % as relation of migrated cells toward the cytokines SDF-1 and VEGF in comparison to the migrated cells without chemokine. Colony forming unit is expressed as number of colonies per 1 × 105seeded MNCs. Values are mean ± SD. p+ = t0 vs. t1; p# = t1 vs. t2; p§ = t0 vs. t2
Figure 6Quantitative evaluation of migration capacity of CPCs in boyden chamber. Relative amount of migrated cells to SDF-1 (a) and VEGF (b) in comparison to cells without chemokines in blood samples of patients with STEMI and exercise training and patients with STEMI and traditional rehabilitation, blood samples were analyzed at 3 different time points. Values are expressed as % of migrated cells without chemokine. Values are mean ± SD.